Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
Status:
Completed
Trial end date:
2022-12-22
Target enrollment:
Participant gender:
Summary
Objective: The purpose of this study was to evaluate the clinical efficacy and safety of
Ningmitai capsule alone or in combination with sildenafil compared with sildenafil alone in
the treatment of CP/CPPS with erectile dysfunction.
Study Design: A multicenter, prospective, randomized and positive drug-controlled clinical
study design was adopted.
Interventions:
① Western medicine group (sildenafil): Sildenafil citrate, 25mg/capsule, once a night, one
capsule each time, for 4 weeks.
② Chinese medicine group (Ningmitai capsule): Ningmitai capsule, 0.38 g/capsule, 3 times a
day, 4 capsules each time, taken after meals for 4 weeks continuously.
③ Combination group (Ningmitai capsule + sildenafil): Ningmitai capsule, 0.38 g/capsule, 3
times a day, 4 capsules each time, taken after meals; Sildenafil citrate, 25mg/capsule, once
a night, one capsule each time, was taken continuously for 4 weeks.